PPP

BEHAVIORAL3 trials

Sponsors

University Hospital, Tours, Puerta de Hierro University Hospital, Virginia Commonwealth University

Conditions

Erectile DysfunctionPersonalized Pharmaceutical Plan After TranspantationQuality of Life

Phase 2

Clinical Trial to Evaluate the Efficacy of Intracavernosal Infusion of PRP vs PPP for the Erectile Dysfunction.

Puerta de Hierro University HospitalErectile Dysfunction

Start: 2020-02-10End: 2022-08-31Target: 52Updated: 2020-08-06

Unknown Phase

Establishment of a Personalized Pharmaceutical Plan in Renal or Hepatic Transplant Patients

University Hospital, ToursPersonalized Pharmaceutical Plan After Transpantation

Start: 2020-10-12End: 2025-09-11Target: 1716Updated: 2022-11-03

RHWP Prescription Produce Plan

CompletedNCT04995237

Virginia Commonwealth UniversityQuality of Life

Start: 2021-08-05End: 2021-12-16Updated: 2023-05-03

Related Papers

MP47-01 PRePED STUDY: A RANDOMISED, DOUBLE-BLIND CONTROLLED TRIAL TO EVALUATE THE EFFICACY OF INTRACAVERNOSAL INFUSION OF PLATELET RICH PLASMA (PRP) AGAINST CONTROL (PLATELET POOR PLASMA) IN THE TREATMENT OF VASCULOGENIC ERECTILE DYSFUNCTION PRELIMINARY RESULTS

The Journal of Urology2024-04-15

Implementing a personalized pharmaceutical plan in kidney or liver transplant patients: study protocol for a stepped-wedge cluster randomized trial (GRePH).

2021-11-082 citations